Recital 5, Regulation (EU) 2026/2046

In forcesince 14 Sep 2026

On 27 February 2026, the Agency transmitted to the Commission the revised summary of the product characteristics of the Union authorisation for the biocidal product family ‘SOPUROXID’ in all official languages of the Union, covering the administrative and minor changes recommended by the Agency, in accordance Article 12(6) of Implementing Regulation (EU) No 354/2013.